Moreover, panobinostat can effectively induce leukemic cell death in t (4; 11)-positive primary infant ALL cells through the inhibition of MLL-AF4 fusion product (Stumpel et al., 2012). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.